Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
t-den- f19 (1 trial)
tdenv-f17 (1 trial)
Dengue (Phase 2)
Fever (Phase 2)
Hemorrhagic Fevers, Viral (Phase 2)
Severe Dengue (Phase 2)
Shock (Phase 2)
Trials (1 total)
Trial APIs (2 total)